Clinical Trial Update: Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating induction chemotherapy followed by concurrent radiation with either cetuximab or cisplatin in locally advanced nasopharyngea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• ERBITUX (cetuximab)

Snippet

Sponsor: Fudan University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN